🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 20 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/08/2007 | 48,52 | 48,61 | 47,71 | 47,82 | -1,38% | 1,85% | 8.010.388 |
| 24/08/2007 | 48,19 | 48,53 | 47,80 | 48,49 | +0,63% | 1,52% | 7.490.475 |
| 23/08/2007 | 48,39 | 48,42 | 47,67 | 48,19 | +0,28% | 1,54% | 10.289.264 |
| 22/08/2007 | 47,97 | 48,44 | 47,35 | 48,05 | +1,19% | 2,27% | 11.241.162 |
| 21/08/2007 | 47,73 | 48,21 | 46,51 | 47,49 | -0,42% | 3,56% | 8.716.530 |
| 20/08/2007 | 47,35 | 48,65 | 47,12 | 47,69 | +0,73% | 3,24% | 8.505.463 |
| 17/08/2007 | 47,79 | 47,96 | 46,37 | 47,35 | +0,32% | 3,31% | 17.209.942 |
| 16/08/2007 | 47,33 | 47,68 | 45,91 | 47,19 | -0,64% | 3,75% | 21.263.396 |
| 15/08/2007 | 47,76 | 48,28 | 47,13 | 47,50 | -0,30% | 2,42% | 10.967.320 |
| 14/08/2007 | 48,24 | 48,42 | 47,57 | 47,64 | -1,25% | 1,76% | 8.880.438 |
| 13/08/2007 | 48,10 | 49,24 | 48,10 | 48,24 | -0,63% | 2,36% | 8.458.513 |
| 10/08/2007 | 49,08 | 49,33 | 47,76 | 48,55 | -1,09% | 3,21% | 16.039.430 |
| 09/08/2007 | 49,22 | 50,10 | 47,95 | 49,08 | -1,76% | 4,36% | 15.497.510 |
| 08/08/2007 | 49,78 | 50,32 | 48,59 | 49,96 | +1,41% | 3,49% | 11.980.526 |
| 07/08/2007 | 48,55 | 49,95 | 48,47 | 49,27 | +0,55% | 3,05% | 14.165.187 |
| 06/08/2007 | 48,86 | 49,22 | 48,15 | 49,00 | +2,11% | 2,19% | 13.726.494 |
| 03/08/2007 | 49,29 | 49,35 | 47,94 | 47,99 | -2,61% | 2,86% | 11.747.137 |
| 02/08/2007 | 49,07 | 49,74 | 48,49 | 49,27 | +1,22% | 2,55% | 13.222.721 |
| 01/08/2007 | 47,35 | 48,92 | 47,30 | 48,68 | +2,76% | 3,43% | 17.262.656 |
| 31/07/2007 | 48,00 | 48,15 | 47,23 | 47,38 | -0,94% | 1,91% | 15.072.546 |
| 30/07/2007 | 48,06 | 48,06 | 47,19 | 47,82 | +0,00% | 1,83% | 12.122.740 |
| 27/07/2007 | 49,59 | 49,78 | 47,78 | 47,82 | -3,56% | 4,04% | 17.475.190 |
| 26/07/2007 | 50,57 | 51,27 | 49,13 | 49,59 | -2,64% | 4,23% | 22.877.316 |
| 25/07/2007 | 49,95 | 51,22 | 49,81 | 50,94 | +3,21% | 2,83% | 19.905.607 |
| 24/07/2007 | 50,52 | 51,35 | 49,17 | 49,35 | -1,17% | 4,31% | 17.923.630 |
| 23/07/2007 | 49,18 | 50,91 | 48,84 | 49,93 | +6,75% | 4,21% | 41.864.561 |
| 20/07/2007 | 47,28 | 47,71 | 46,57 | 46,77 | -0,65% | 2,40% | 14.354.142 |
| 19/07/2007 | 47,69 | 47,77 | 46,87 | 47,08 | -1,20% | 1,88% | 11.842.819 |
| 18/07/2007 | 47,71 | 48,07 | 47,07 | 47,65 | -0,66% | 2,10% | 11.154.598 |
| 17/07/2007 | 48,33 | 48,76 | 47,83 | 47,97 | -1,10% | 1,91% | 8.095.381 |